Allergy and Immunology · Northbrook, IL
NPI
1689864357
Since 2007
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 Skokie Blvd, Suite 140
Northbrook, IL, 60062
Phone (847) 272-4296
Groups this clinician bills Medicare through
Medicare paid, 2024
$385K
19,969 services
Medicare patients, 2024
281
Average age 72
Drug cost, 2024
$280K
848 prescriptions
Company payments, 2025
$1,341
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John K Lawson was code J2357 (injection, omalizumab, 5 mg), 5,160 times for 15 patients. In total John K Lawson billed 19,969 services in 26 codes, and Medicare paid $385K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 5,160 | 15 | $29.91 | $154K |
| 95004 Test - Miscellaneous | Office | 1,212 | 36 | $2.98 | $3,610 |
| 95165 Treatment - Miscellaneous | Office | 707 | 44 | $10.91 | $7,713 |
| 95117 Treatment - Miscellaneous | Office | 631 | 89 | $8.60 | $5,426 |
| 99214 Office E&M - Established | Office | 185 | 114 | $94.78 | $18K |
| 99213 Office E&M - Established | Office | 184 | 119 | $65.42 | $12K |
| 96401 Chemotherapy Administration | Office | 154 | 26 | $55.43 | $8,536 |
| 95044 Test - Miscellaneous | Office | 78 | 12 | $4.26 | $332 |
| 99204 Office E&M - New | Office | 42 | 42 | $129.99 | $5,460 |
| 99212 Office E&M - Established | Office | 29 | 24 | $45.40 | $1,317 |
| 94010 Pulmonary Function Testing | Office | 27 | 27 | $20.93 | $565 |
| 99203 Office E&M - New | Office | 25 | 25 | $71.59 | $1,790 |
By year: 2022 $163K for 6,741 services; 2023 $197K for 9,698 services; 2024 $385K for 19,969 services.
Medicare prescription drug claims, 2024
In 2024, the drug John K Lawson prescribed most often to Medicare patients was Ipratropium Bromide, with 115 prescriptions and refills. In total John K Lawson wrote 848 Medicare prescriptions that cost $280K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 115 | 164 | 28 | $3,182 |
| Montelukast Sodium Generic | 72 | 192 | 25 | $609 |
| Prednisone Generic | 67 | 79 | 32 | $355 |
| Azelastine Hcl Generic | 56 | 78 | 21 | $1,221 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 55 | 60 | 24 | $1,510 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 42 | 83 | 15 | $52K |
| Fluticasone Propionate Generic | 36 | 73 | 17 | $585 |
| Breo Ellipta Fluticasone/Vilanterol | 31 | 71 | Under 11 | $27K |
| Arnuity Ellipta Fluticasone Furoate | 30 | 44 | Under 11 | $8,952 |
| Qvar Redihaler Beclomethasone Dipropionate | 24 | 28 | Under 11 | $6,551 |
| Epinephrine Generic | 18 | 18 | 16 | $2,969 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 18 | 20 | Under 11 | $1,833 |
| Levocetirizine Dihydrochloride Generic | 16 | 46 | Under 11 | $301 |
| Triamcinolone Acetonide Generic | 16 | 18 | 12 | $181 |
| Omeprazole Generic | 15 | 37 | Under 11 | $161 |
Brand drugs: - claims; generic drugs: 555 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John K Lawson $1,341 ($1,341 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $366.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $366 |
| Regeneron Healthcare Solutions, Inc. REGN | 11 | $335 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $181 |
| Genentech USA, Inc. ROG.SW | 4 | $82.8 |
| GlaxoSmithKline, LLC. GSK | 3 | $64.06 |
| Hospira, Inc. PFE | 2 | $42.45 |
| Galderma Laboratories, L.P. GALD.SW | 2 | $38.98 |
| Genzyme Corporation SNY | 1 | $32.82 |
| Grifols USA, LLC | 2 | $32.13 |
| Cycle Pharmaceuticals Inc | 2 | $30.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.